In today's ACT Brief, we examine quantified reductions in trial visits through selective safety data collection, why protocol ...
Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...
In today's ACT Brief, we examine what the FDA's real-time oversight initiative demands of sponsors, why clinical data ...
In today's ACT Brief, we recap key themes from DIA 2026 on operational priorities and regulatory shifts, examine ...
FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...
Microsoft 365 Copilot deployment aims to automate high-volume, repeatable work, freeing clinical operations staff for ...
Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract
This article argues that improving financial outcomes—including more reliable revenue recognition—requires revisiting the ...
In today's ACT Brief, we examine regulatory uncertainty and 2026 breakthroughs shaping clinical research, reimagining CRO ...
In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...
In this video interview, Marwan Fathallah, president and CEO of DIA Global, shares the key trends and themes shaping this ...
In this video interview following the 2026 DIA Global Annual Meeting, Jonathan Andrus, co-CEO of CRIO, explains why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results